BR100 Increased By (0.36%)
BR30 Decreased By (-0.13%)
KSE100 Increased By (0.22%)
KSE30 Increased By (0.37%)
AGHA 6.68 Increased By ▲ 0.01 (0.15%)
BECO 4.37 No Change ▼ 0.00 (0%)
BML 57.32 Increased By ▲ 0.88 (1.56%)
BOP 30.35 Increased By ▲ 0.01 (0.03%)
CNERGY 13.12 Increased By ▲ 0.03 (0.23%)
CSIL 5.41 Increased By ▲ 0.05 (0.93%)
FCCL 52.79 Increased By ▲ 0.41 (0.78%)
FFL 14.72 Decreased By ▼ -0.02 (-0.14%)
FNEL 1.12 No Change ▼ 0.00 (0%)
KEL 6.09 No Change ▼ 0.00 (0%)
KOSM 5.73 Increased By ▲ 0.77 (15.52%)
LOTCHEM 26.46 Decreased By ▼ -0.89 (-3.25%)
MLCF 93.16 Increased By ▲ 0.41 (0.44%)
NBP 164.66 Decreased By ▼ -0.32 (-0.19%)
NCPL 55.66 Increased By ▲ 0.02 (0.04%)
NPL 61.16 Decreased By ▼ -0.10 (-0.16%)
OGDC 316.73 Decreased By ▼ -1.03 (-0.32%)
PACE 9.87 Decreased By ▼ -0.06 (-0.6%)
PAEL 35.63 Increased By ▲ 0.13 (0.37%)
PIBTL 14.68 Increased By ▲ 0.11 (0.75%)
PPL 226.91 Decreased By ▼ -0.88 (-0.39%)
PRL 93.02 Increased By ▲ 0.45 (0.49%)
PTC 60.26 Decreased By ▼ -0.37 (-0.61%)
SSGC 23.81 Increased By ▲ 0.01 (0.04%)
TBL 8.75 Increased By ▲ 0.07 (0.81%)
TELE 7.80 Increased By ▲ 0.02 (0.26%)
TPL 22.35 Increased By ▲ 0.12 (0.54%)
TPLP 12.97 Increased By ▲ 0.30 (2.37%)
TREET 22.16 Decreased By ▼ -0.38 (-1.69%)
TRG 56.56 Decreased By ▼ -1.24 (-2.15%)

imageLONDON: Britain's top share index advanced on Wednesday, with Hikma Pharmaceuticals leading the market higher on positive broker comments and GlaxoSmithKline gaining after reporting a lower-than-expected fall in quarterly earnings.

Hikma shares were the biggest blue-chip gainers after a target price update from Jefferies, adding 3.7 percent to an 11.6 percent jump on Tuesday, when it announced a deal to buy Boehringer Ingelheim's US generic drugs business Roxane for about $2.65 billion in cash and stock.

"The deal has created a firm foundation for future growth," said Augustin Eden, analyst at Accendo Markets. "Hikma shares could be bound for a return to February highs and above - still a healthy 8.5 percent away despite gains of yesterday." The blue-chip FTSE 100 index closed 1.2 percent higher at 6,631.00 points after rising 0.8 percent in the previous session, when it snapped a five-day losing streak.

Drugmaker GlaxoSmithKline gained 3.5 percent after flagging up dozens of new drugs and vaccines in development as demand for new HIV medicines helped it beat quarterly profit forecasts.

Barclays shares were up nearly 2 percent after the bank, which reported a 12 percent rise in profit, said it intended to accelerate the sale of assets and cost cutting. "Barclays appears eager to press ahead with the increased pace of restructuring.

Most of the key metrics continue to show improvement, with a reduction in operating expenses and impairments being complemented by another robust income showing, leading to a notable hike in adjusted profits," said Richard Hunter, head of equities at Hargreaves Lansdown.

"In addition, the capital cushion remains comfortable and the return on equity is showing some signs of life." British American Tobacco advanced 3.6 percent after reporting a better-than-expected performance for the second quarter.

Small-cap Quintain Estates and Development jumped 22 percent on news that it is to be bought by US private equity firm Lone Star after receiving a bid valuing the firm at around 700 million pounds ($1.1 billion).

On the downside, Compass Group, the world's biggest catering firm, fell 5.3 percent after saying operating profit this year and next would be hit by restructuring costs.

Mid-cap engineering supply group Premier Farnell slumped 16 percent following comments that it expected a 10 percent fall in first-half adjusted operating profit after sales growth per day in its main markets slowed in the second quarter.

Copyright Reuters, 2015

Comments

Comments are closed for this article.